![]() SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. | ![]() SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. | |||
Founding Date | Founding Date 1979 | Founding Date 2001 | Founding Date 2017 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations Lane Cove West, AU HQ Gif Sur Yvette, FR Hamburg, DE Shibuya, JP Clayton West, GB Indianapolis, US | Locations Salt Lake City, US HQ Wuxi, CN Walluf, DE Willich, DE Milano, IT Doetinchem, NL Calamba, PH see more | Locations Boulder, US HQ |
Employees | Employees 3699% increase | Employees 466 | Employees 2,4004% increase | Employees 483 |
Valuation ($) | Valuation ($) 539.3 m | Valuation ($) 760.8 m | Valuation ($) 543.9 m | Valuation ($) 396.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $126.1m (FY, 2024) | Revenue (est.) $198.6m (FY, 2025) | Revenue (est.) $844.6m (FY, 2025) | Revenue (est.) $97.7m (FY, 2022) |
Cost of goods | Cost of goods $33m (FY, 2024) | Cost of goods $35.2m (FY, 2025) | Cost of goods $554.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $93.1m (FY, 2024) | Gross profit $164.7m (FY, 2025) | Gross profit $290.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($11.5m) (FY, 2024) | Net income $20.7m (FY, 2025) | Net income ($69.9m) (FY, 2025) | Net income ($109.2m) (FY, 2022) |

Nanosonics is a company that specializes in the field of infection prevention.
View company
Varex Imaging is a developer and manufacturer of X-ray imaging components.
View company
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View company